Phil Bradshaw to Lead Business Operations
LONDON--(BUSINESS WIRE)--Mar. 5, 2018--
Intuitive Surgical has named Phil Bradshaw as its first General Manager
in the United Kingdom and Ireland (UK&I). Mr. Bradshaw will direct
business strategy and operations for the company in these countries.
This press release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20180305005586/en/
Intuitive Surgical Announces First General Manager in UK & Ireland. Phil Bradshaw to Lead Business Operations. (Photo: Business Wire)
Intuitive pioneered the field of robotic-assisted, minimally invasive
surgery with the creation of its da Vinci Surgical System. Now on
its fourth-generation system, the Silicon Valley, California-based
company has seen more than five million robotic-assisted surgical procedures
performed worldwide, and the da Vinci Surgical Systems’ benefits
explored in more than 15,000 peer-reviewed scientific publications
to-date.
“Our commitment to the UK & Ireland has been increasing since we entered
these markets ten years ago. Phil’s deep knowledge of the medical device
industry and his enthusiasm for continued innovation in the UK and Irish
markets, expands that commitment,” said Dr. Gary Guthart, CEO of
Intuitive. “British surgeons have been at the forefront of driving
innovation and improvements in patient care and economic value to the
NHS using da Vinci robotic systems, where patients can recover
and return home more quickly, saving the healthcare system money,” he
added.
Mr. Bradshaw brings nearly three decades of experience in the medical
device field working for market-leading companies, and more than eight
years of general management experience in the UK and European markets.
“Intuitive’s impressive experience and track record of working with
surgeons to provide continuous developments in robotic-assisted surgery
in the UK and Ireland was very important to me,” said Bradshaw. “The
company’s commitment to ensuring that robotic-assisted surgery becomes a
standardised option for surgeons in an increasing number of indications,
will allow me to serve as a champion for increased patient access here
in the UK and Ireland,” he continued.
Before joining Intuitive Surgical, Mr. Bradshaw worked at Medtronic as
Strategic Alliance Director for EMEA within the Integrated Health
Solutions Division. Prior to Medtronic, he established the Head & Neck
Division at Stryker UK, working in the Neurosurgical and Cranio-maxillio
facial market. Additionally, Mr. Bradshaw spent 18 years with Synthes, a
medical device company specialising in orthopaedics, where he fulfilled
a variety of graduated sales and marketing positions, including GM roles
in both the UK and Portugal.
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (Nasdaq:ISRG), headquartered in Sunnyvale,
California, is the pioneer in robotic-assisted, minimally invasive
surgery. Intuitive Surgical develops, manufactures and markets the da
Vinci Surgical System. The Company's mission is to make surgery more
effective, less invasive and easier on surgeons, patients and their
families.
About the da Vinci Surgical
System
There are several models of the da Vinci Surgical System. The da
Vinci Surgical Systems are designed to help surgeons perform
minimally invasive surgery. da Vinci Systems offer surgeons
high-definition 3D vision, a magnified view, and robotic and computer
assistance. They use specialized instrumentation, including a
miniaturized surgical camera and wristed instruments (i.e., scissors,
scalpels and forceps) that are designed to help with precise dissection
and reconstruction deep inside the body.
© 2018 Intuitive Surgical, Inc. All rights reserved. Intuitive Surgical®,
da Vinci®, da Vinci S®, da Vinci®
Si™, da Vinci Xi®, da Vinci X®,
OnSite® and EndoWrist® are trademarks or
registered trademarks of Intuitive Surgical, Inc.
For more information, please visit the company's web site at www.intuitivesurgical.com.
Important Safety Information
Serious complications may occur in any surgery, including da Vinci®
Surgery, up to and including death. Risks include, but are not
limited to, injury to tissues and organs and conversion to other
surgical techniques. If your doctor needs to convert the surgery to
another surgical technique, this could result in a longer operative
time, additional time under anesthesia, additional or larger incisions
and/or increased complications. Individual surgical results may vary.
Patients who are not candidates for non-robotic minimally invasive
surgery are also not candidates for da Vinci® Surgery.
Patients should talk to their doctors to decide if da Vinci®
Surgery is right for them. Patients and doctors should review all
available information on non-surgical and surgical options in order to
make an informed decision. Please also refer to www.daVinciSurgery.com/Safety
for Important Safety Information.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180305005586/en/
Source: Intuitive Surgical, Inc.
For Intuitive Surgical:
JPA Health Communications
Kate Perry,
020 3884 0650
isipr@jpa.com